Viral Hepatitis in Asia and the Pacific :Towards Elimination as a Public Health Threat

Viral Hepatitis in Asia and the Pacific

Viral Hepatitis in Asia and the Pacific :Towards Elimination as a Public Health Threat

(Author) (Author) (Author)
paperback
Published: 15 July, 2025
Standard worldwide delivery by Thu, June 25 - Tue, June 30
Order within 0
Condition: NEW
$140.30
RRP $178.76
You save $38.46 (22%)
Price includes shipping
Available 20 in stock
- +
FREE Returns within 30 days

Description

Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination. Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.
See more

More Details

Type Book
ISBN13 9780443236297
ISBN10 0443236291
Number Of Pages 282
Item Weight 450 g
Publisher / Reseller Elsevier Science Publishing Co Inc
Format paperback
See More +

Author's Bio

Dr. Sun is the Professor for Pharmaceutical Policy of the Chinese Academy of Medical Sciences and Peking Union Medical College. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. She received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands, MSc. of International Health Policy from London School of Economics of the UK, and Bachelor of Pharmaceutical Chemistry from Peking Medical University of China. Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women’s health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine. Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).

Show more